News - Duchenne muscular dystrophy
2012-05-22 02:27:43
NEWTON, Mass., May 22, 2012 /PRNewswire/ -- Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that
2012-05-03 06:27:12
Larger Community Roundtable on Trial Design Planned HACKENSACK, N.J., May 3, 2012 /PRNewswire-USNewswire/ -- Parent Project
2012-05-03 02:31:18
Muscular Dystrophy Association has awarded ReveraGen BioPharma $1.5 million to develop drug TUCSON, Ariz., May 3, 2012 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association
2012-04-24 06:26:30
Louisiana's Tim Rice Begins Trek to Raise Duchenne Awareness HACKENSACK, N.J., April 24, 2012 /PRNewswire-USNewswire/ -- Parent
